Cargando…
Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome
TMAO is a new risk biomarker for cardiovascular disease. With trimethylammonium as its main chemical skeleton, TMAO is structurally similar to many endogenous metabolites, such as acetylcholine, carnitine, phosphorylcholine, etc. The mechanism of TMAO on the pathological process of CVD is still uncl...
Autores principales: | Lei, Dongyu, Yu, Wenbo, Liu, Yi, Jiang, Yujie, Li, Xiaohui, Lv, Jing, Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180140/ https://www.ncbi.nlm.nih.gov/pubmed/37175227 http://dx.doi.org/10.3390/molecules28093817 |
Ejemplares similares
-
A validated simple LC-MS/MS method for quantifying trimethylamine N-oxide (TMAO) using a surrogate matrix and its clinical application
por: Li, Yufei, et al.
Publicado: (2021) -
Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021) -
NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy
por: Zhang, Yan-Zi, et al.
Publicado: (2019) -
NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013) -
Pharmacokinetic and Metabolism Studies of Curculigoside C by UPLC-MS/MS and UPLC-QTOF-MS
por: Wu, Di, et al.
Publicado: (2018)